Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125362701 | 12536270 | 1 | I | 2016 | 20160705 | 20160707 | 20160707 | EXP | US-GLAXOSMITHKLINE-US2016GSK096312 | GLAXOSMITHKLINE | 51.18 | YR | F | Y | 70.31000 | KG | 20160707 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125362701 | 12536270 | 1 | PS | WELLBUTRIN XL | BUPROPION HYDROCHLORIDE | 1 | 150 MG, UNK | 18644 | 150 | MG | TABLET | ||||||||
| 125362701 | 12536270 | 2 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 50 MG, QD | N | U | 0 | 50 | MG | QD | |||||
| 125362701 | 12536270 | 3 | C | ROPINIROLE HYDROCHLORIDE. | ROPINIROLE HYDROCHLORIDE | 1 | 0.5 MG, UNK | 0 | .5 | MG | TABLET | ||||||||
| 125362701 | 12536270 | 4 | C | METHOCARBAMOL. | METHOCARBAMOL | 1 | 750 MG, UNK | 0 | 750 | MG | |||||||||
| 125362701 | 12536270 | 5 | C | ALLEGRA | FEXOFENADINE HYDROCHLORIDE | 1 | 180 MG, QD | 0 | 180 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125362701 | 12536270 | 1 | Depression |
| 125362701 | 12536270 | 2 | Depression |
| 125362701 | 12536270 | 3 | Restless legs syndrome |
| 125362701 | 12536270 | 4 | Pain |
| 125362701 | 12536270 | 5 | Multiple allergies |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125362701 | 12536270 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125362701 | 12536270 | Alopecia | |
| 125362701 | 12536270 | Bipolar II disorder | |
| 125362701 | 12536270 | Feeling jittery | |
| 125362701 | 12536270 | Hair texture abnormal | |
| 125362701 | 12536270 | Incorrect dose administered | |
| 125362701 | 12536270 | Intentional product misuse | |
| 125362701 | 12536270 | Pruritus | |
| 125362701 | 12536270 | Rash | |
| 125362701 | 12536270 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125362701 | 12536270 | 1 | 201510 | 0 | ||
| 125362701 | 12536270 | 2 | 201604 | 0 | ||
| 125362701 | 12536270 | 3 | 201507 | 0 | ||
| 125362701 | 12536270 | 4 | 201507 | 0 |